Author: Ravi Shankar

The Plug & Play and Smart Home Technologies Are Expected to Be Supplied to Projects in Oklahoma and Texas

Home Creations Has Been Building Homes and Communities Since 1981

MIAMI, Oct. 26, 2026 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (the “Company” or “SKYX”), a highly disruptive platform technology company with over 120 patents and pending applications globally and 60 lighting and home décor websites, with a mission to make homes and buildings become safe and smart as the new standard, today announced that SKYX and its subsidiary Deako expect to supply approximately 60,000 units of their advanced technologies in the next 12 months to over 700 homes to Oklahoma and Texas community and home builder Home Creations, as the Company continues to grow its market penetration.

Founded in 1981, Home Creations is a family-founded homebuilder serving Oklahoma and the Houston, Texas, market. Its neighborhoods offer amenities including clubhouses, community pools, fitness centers, playgrounds, sidewalks, and green spaces. Amenities vary by community and are not available in every Home Creations neighborhood.

Home Creations combines energy-efficient construction with smart home features. Its Oklahoma City homes are nearly 53% more energy efficient than typical new homes and include Deako smart lighting, a smart thermostat, smart locks, and an app-enabled garage door. Every home is HERS-verified by a certified RESNET energy rater and backed by a 10-year structural warranty. The smart home features and efficiency figures described above apply to Oklahoma City homes.

Home Creations Development

SKYX Deako highlights since merger closing:

• Home Creations: over 60,000 units for over 700 homes in Oklahoma and Texas.
• Maronda Homes: over 80,000 units for 1,000 homes.
• Since closing: over 140,000 units across more than 1,700 homes
• Combined pipeline estimated at over 4 million units, with an expected average selling price of approximately $50 per product.
• Deako brings over 32 million units shipped, over $26 million in 2025 revenue and relationships with more than 50 U.S. homebuilders including D.R. Horton and Toll brothers.
• SKYX and Deako creating an A-to-Z smart home offering for the builder and hotel markets.
• Full combined product line could increase future revenue per home by up to five times.
• Merger expected to reduce annual cash expenses by over $6 million.

For information about Home Creations, visit www.homecreations.com.

For more information about SKYX and Deako, visit www.SKYX.com and www.Deako.com.

Derek Richardson, Founder and CEO of Deako, stated: “We are excited to grow our work with Home Creations to bring our smart home technologies to more homeowners in Oklahoma and Texas. Home Creations’ focus on energy efficiency, connected living, and thoughtfully designed communities makes this a natural fit for Deako. Our technology provides a smart lighting foundation that is simple for builders to install and easy for homeowners to customize and expand.”

Rani Kohen, Founder and Executive Chairman of SKYX Platforms, said: “We are very pleased to be working with another prominent home builder, Home Creations. We expect to keep expanding our builder programs with our subsidiary Deako and look forward to continuing to grow our market penetration while creating safer, more advanced, and smarter homes and buildings of the future.”

About SKYX Platforms Corp.

As electricity is a standard in every home and building, our mission is to make homes and buildings become safe-advanced and smart as the new standard. SKYX has a series of highly disruptive advanced, safe, smart and AI platform technologies, with over 120 U.S. and global patents and patent pending applications. Additionally, the Company owns 60 lighting and home décor websites for both retail and commercial segments. Our technologies place an emphasis on high quality and ease of use, while significantly enhancing both safety and lifestyle in homes and buildings. We believe that our products are a necessity in every room in both homes and other buildings in the U.S. and globally. For more information, please visit our website at https://www.skyx.com/ or follow us on LinkedIn.

Forward-Looking Statements

Certain statements made in this press release are not based on historical facts, but are forward-looking statements. These statements can be identified by the use of forward-looking terminology such as “aim,” “anticipate,” “believe,” “can,” “could,” “continue,” “estimate,” “expect,” “evaluate,” “forecast,” “guidance,” “intend,” “likely,” “may,” “might,” “objective,” “ongoing,” “outlook,” “plan,” “potential,” “predict,” “probable,” “project,” “seek,” “should,” “target,” “view,” “will,” or “would,” or the negative thereof or other variations thereon or comparable terminology, although not all forward-looking statements contain these words. These statements reflect the Company’s reasonable judgment with respect to future events and are subject to risks, uncertainties and other factors, many of which have outcomes difficult to predict and may be outside our control, that could cause actual results or outcomes to differ materially from those in the forward-looking statements. Such risks and uncertainties include statements relating to the Company’s ability to successfully launch, commercialize, develop additional features and achieve market acceptance of its products and technologies and integrate its products and technologies with third-party platforms or technologies; the Company’s ability to achieve positive cash flows; the Company’s efforts and ability to drive the adoption of its products and technologies as a standard feature, including their use in homes, hotels, offices and cruise ships; the Company’s ability to capture market share; the Company’s estimates of its potential addressable market and demand for its products and technologies; the Company’s ability to raise additional capital to support its operations as needed, which may not be available on acceptable terms or at all; the Company’s ability to continue as a going concern; the Company’s ability to execute on any sales and licensing or other strategic opportunities; the possibility that any of the Company’s products will become National Electrical Code (NEC)-code or otherwise code mandatory in any jurisdiction, or that any of the Company’s current or future products or technologies will be adopted by any state, country, or municipality, within any specific timeframe or at all; risks arising from mergers, acquisitions, joint ventures and other collaborations; the Company’s ability to attract and retain key executives and qualified personnel; guidance provided by management, which may differ from the Company’s actual operating results; the potential impact of unstable market and economic conditions on the Company’s business, financial condition, and stock price; and other risks and uncertainties described in the Company’s filings with the Securities and Exchange Commission, including its periodic reports on Form 10-K and Form 10-Q. There can be no assurance as to any of the foregoing matters. Any forward-looking statement speaks only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by U.S. federal securities laws.

Investor Relations Contacts:

Jeff Ramson
PCG Advisory
jramson@pcgadvisory.com

Ronald A. Both
Encore Investor Relations
rb@encore-ir.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a2269f18-0763-4f38-9e3d-4207759756a4

New market entries follow expanded product offerings in Florida, South Carolina and California, advancing Slide’s geographic and product diversification

TAMPA, Fla., Oct. 26, 2026 (GLOBE NEWSWIRE) — Slide Insurance Holdings, Inc. (“Slide” or the “Company”) (NASDAQ: SLDE) today announced it is open for new business in Texas and Rhode Island. The new market entries follow expanded product offerings in Florida, South Carolina and California, and reflect Slide’s strategy of disciplined growth and geographic diversification into markets where its underwriting and catastrophe risk management capabilities provide Slide with a competitive advantage. 

Slide is entering Texas with an HO3 homeowners insurance product and Rhode Island with a DP3 dwelling insurance product for eligible rental and seasonal properties. The offerings extend the Company’s reach into two additional states, providing new coverage options for property owners and expanding the solutions available to independent agents.

“Our entries into Texas and Rhode Island are fully aligned with our long-term diversified growth strategy to expand into attractive new markets,” said Bruce Lucas, Chairman and Chief Executive Officer of Slide. “Texas represents one of the largest homeowners insurance markets in the United States, while Rhode Island establishes a foothold for further expansion across the Northeast. Our underwriting expertise, technology and financial strength position us to grow with discipline while bringing additional choice and capacity to the communities we serve.”

In Texas, Slide’s homeowners offering provides an additional option for eligible homeowners in a market where catastrophe exposure and coverage costs remain important considerations. In Rhode Island, the Company’s dwelling product addresses the needs of landlords and seasonal property owners, adding choice in a market facing increased underwriting selectivity, particularly in coastal communities.

The expansion builds on Slide’s experience underwriting catastrophe-exposed residential properties and its focus on matching products to the needs of individual markets. By broadening both its geographic footprint and product portfolio, the Company continues to diversify its business and strengthen its foundation for long-term growth.

Participating independent agents can access the new offerings through Violet, Slide’s proprietary quoting and policy management platform.

Forward-Looking Statements

Statements in this press release that are not historical facts are forward-looking statements that are subject to certain risks and uncertainties that could cause actual events and results to differ materially from those discussed herein. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “aim,” “estimates,” “predicts,” “potential” or “continue,” the negative of these terms and other comparable terminology and relate, without limitation, to the Company’s beliefs and expectations regarding the Company’s projections of future financial performance including net margins and its share repurchase program and its ability to increase return on equity and build long-term value for shareholders. These statements are only predictions based on Slide’s current expectations and projections about future events and are not guarantees of actual results, level of activity, performance or achievements. Although Slide believes the expectations reflected in the forward-looking statements are based on reasonable assumptions, there are important factors that could cause the Company’s actual results, level of activity, performance or achievements to differ materially from those anticipated in any forward-looking statements, including, among others, our limited operating history; the success of the Company’s underwriting and profitability initiatives; inflation and other changes in economic conditions (including changes in interest rates and financial and real estate markets), including changes that may impact demand for our products and our operations; lack of effectiveness of exclusions and loss limitation methods in the insurance policies we assume or write; inherent uncertainty of our models and our reliance on such models as a tool to evaluate risk; the impact of macroeconomic conditions, including declining consumer confidence, inflation, high unemployment and the threat of recession; the impact of new federal and state regulations that affect the property and casualty insurance market and our failure to meet increased regulatory requirements, including minimum capital and surplus requirements; the cost of reinsurance, the collectability of reinsurance and our ability to obtain reinsurance coverage on terms and at a cost acceptable to us; assessments charged by various governmental agencies; pricing competition and other initiatives by competitors; our ability to obtain regulatory approval for requested rate changes, and the timing thereof; legislative and regulatory developments; the outcome of litigation pending against us, including the terms of any settlements; risks related to the nature of our business; performance of our investment portfolio; the adequacy of our liability for losses and loss adjustment expense; ratings by industry services; catastrophe losses; reliance on key personnel; weather conditions (including the severity and frequency of storms, hurricanes, tornadoes, wildfires and hail); acts of war and terrorist activities; court decisions and trends in litigation; and other matters described from time to time by us in our filings with the Securities and Exchange Commission. Any forward-looking statement made by Slide in this press release speaks only as of the date on which it is made. Slide undertakes no obligation to update any forward-looking statement, whether as a result of new information, actual results, revised expectations or otherwise, except as may be required by law.

About Slide

Slide Insurance Holdings, Inc. (NASDAQ: SLDE) is a Tampa-based specialty property insurer built for coastal and catastrophe-prone markets. Slide combines advanced technology with deep insurance expertise to maintain a disciplined approach to risk, bring additional capacity to the markets it serves along with its network of more than 5,000 independent agents, and provide a dependable, streamlined insurance experience to its policyholders. Slide ranks among the 25 largest U.S. homeowners insurance groups by direct written premium, according to the National Association of Insurance Commissioners (NAIC). For more information, visit slideinsurance.com.

Contacts

Investors
ir@slideinsurance.com

Media
Rachel Carr
Chief Marketing Officer
press@slideinsurance.com

New platform-independent solution targets commercial fleets, private vehicles and insurance providers, eliminating the need for dedicated in-vehicle hardware

Petah Tikva, Israel, Oct. 26, 2026 (GLOBE NEWSWIRE) — SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company specializing in radio frequency (RF)-based solutions for the advanced transportation safety, defense and homeland security markets, today announced the launch of a software-only version of its driver distraction prevention solution that can integrate into the existing telematics and in-vehicle platforms that fleets already use. This provides an integrated active safety solution that prevents phone distraction while driving, without the need for complex installation of hardware in the vehicle cabin, avoiding vehicle downtime and potential damage. The new solution is designed to expand SaverOne’s addressable market beyond commercial fleets to include private vehicles, telematics service providers and insurance companies.

Most commercial fleets already have an existing telematics system installed in their vehicles and do not want to add another hardware box. SaverOne’s software-only solution brings its driver distraction prevention capabilities to these existing platforms. The driver’s phone is connected to SaverOne’s cloud server, which implements each fleet’s own safety policy. While driving, distracting apps and notifications are blocked, and the apps that the fleet allows continue to work. The solution also identifies when a driver’s phone is not connected to the system, in which case an alert is activated through the telematics system or the vehicle speakers, and a phone call can be initiated to the driver as a reminder to reconnect. Fleet managers have full visibility through a cloud-based dashboard, while the system maintains high privacy standards: no message content, numbers dialed or location data are collected.

SaverOne is in the process of completing the integration of its software-only solution with a few telematics system providers, among them Ituran and Geotab, with the SaverOne product available on the Geotab Marketplace. In addition, the solution has been integrated with the infotainment system of a leading global commercial vehicle manufacturer. Adding these platforms brings a potential base of many millions of vehicles.   

Beyond Commercial Fleets: Unlocking the Private Vehicle and Insurance Markets

Beyond commercial fleets, SaverOne’s software-only solution will also address the significantly larger private passenger vehicle market. Potential channels include existing GPS-based vehicle tracking and telematics providers, and insurers offering young-driver policies in which drivers identify themselves through a mobile app before each trip. Integration with these existing systems could bring distraction prevention to a broad base of private motorists without installing dedicated hardware, creating an additional growth opportunity.

Mr. Ori Gilboa, CEO of SaverOne, stated, “Fleets want active safety, but they do not want to install another box in the vehicle. By delivering our distraction prevention as software on the telematics and in-vehicle platforms that fleets already run, we remove the need for additional hardware and significantly lower the upfront investment for fleets. Our integrations with several major telematics and infotainment platforms will place our solution on platforms that already reach fleets with millions of drivers, and we are now focused on turning these integrations into commercial deployments. Importantly, we see an even broader opportunity beyond commercial fleets, particularly in the private vehicle and insurance markets, where existing telematics and mobile app platforms could enable deployment at a scale previously difficult to address with hardware-based solutions.”

Please visit https://youtu.be/mv-h2QtHMOc to see a live demonstration of the new product.

About SaverOne 2014 Ltd.

SaverOne is a technology company specializing in RF-based solutions for the advanced transportation safety, defense and homeland security markets. SaverOne designs, develops and commercializes OEM and aftermarket technologies that detect, locate and analyze cellphone RF signals using proprietary hardware, software, AI and algorithms.

SaverOne’s first commercial product line is designed to prevent vehicle accidents caused by driver distraction from mobile phone use. Building on the same core RF sensing platform, SaverOne is also developing solutions for vulnerable road user (VRU) detection under limited-visibility and non-line-of-sight conditions, based on the cellphone footprint of pedestrians and other road users.

In 2026, SaverOne expanded the potential applications of its RF sensing technology beyond transportation through its strategic transaction with VisionWave Holdings, Inc. (Nasdaq: VWAV), focused on integrating SaverOne’s RF capabilities into defense, homeland security and critical infrastructure applications.

Learn more at https://saver.one/

Forward–Looking Statements

This press release contains “forward-looking statements“ within the meaning of the Private Securities Litigation Reform Act and other securities laws that are subject to substantial risks and uncertainties. All statements, besides those of historical fact, contained in this press release are forward-looking. Forward-looking statements contained in this press release include, but are not limited to, statements regarding SaverOne’s strategic and business plans, technology, relationships, objectives, and expectations for its business, the impact of trends on and interest in its business, intellectual property or product and its future results, operations, and financial performance and condition and may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will,” “would,” or the negative of these words or other similar expressions. However, not all forward-looking statements contain these words. Forward-looking statements are based on SaverOne’s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions about future events that may not prove accurate. Many factors could cause SaverOne’s actual activities or results to differ materially from those anticipated in such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited to: the ability of our technology to substantially improve the safety of drivers; our ability to protect our patented technology from infringement by third parties; SaverOne’s planned level of revenues and capital expenditures and its ability to continue as a going concern; SaverOne’s ability to maintain its listing on the Nasdaq Capital Market; its ability to market and sell its products; its plans to continue to invest in research and development to develop technology for both existing and new products; SaverOne’s intention to advance its technologies and commercialization efforts in Europe and globally; acceptance of its business model by investors; the ability to correctly identify and enter new markets; the impact of competition and new technologies; general market, political and economic conditions in the countries in which SaverOne operates; projected capital expenditures and liquidity; SaverOne’s intention to retain key employees, and its belief that it will maintain good relations with all employees; as well as other risks and uncertainties, including, but not limited to, the risks detailed in SaverOne’s Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 27, 2026, and in subsequent filings with the SEC. Forward-looking statements in this announcement are made as of this date, and SaverOne undertakes no duty to update such information except as required under applicable law.

International Investor Relations Contact:

Ehud Helft
+1 212 378 8040
saverone@ekgir.com

Available for purchase, the unique in-house system combines proprietary detection, ground-based guidance and reusable interceptors to deliver autonomous perimeter protection; November demonstrations in Israel to precede international demonstrations

Kfar Saba, Israel, Oct. 26, 2026 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “Company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced the launch of TillOnAIR, a complete, in-house developed autonomous Counter-UAS system and the newest addition to its DefendAir product family. Available for purchase, TillOnAIR brings together a combination of capabilities the Company believes represents a first-of-its-kind approach to autonomous perimeter defense.

The launch expands ParaZero’s offering from interception technologies and platform integrations to a complete, proprietary detect-to-defeat solution. TillOnAIR combines a patented detection-and-guidance technology, a ground-based mission control unit, a reusable quadcopter interceptor and a DefendAir Net Pod. The system is designed to operate autonomously throughout the engagement cycle, from detecting an approaching threat through interceptor launch, guidance, net deployment and return, without human intervention.

At the heart of TillOnAIR’s distinctive architecture is the separation of ground-based targeting and guidance from the airborne interceptor. The ground system detects and tracks the threat and guides the interceptor directly from the ground, which requires no onboard GPS, homing seeker, camera or beacon receiver. This architecture enables a simple, lightweight and cost-efficient interceptor within a fully autonomous protection system.

Designed for operation in environments affected by electronic interference, TillOnAIR combines resilience to jamming and spoofing with physical interception that does not depend on disrupting the hostile drone’s communications or navigation. Its net-based defeat mechanism is designed to address fiber-optic-guided, pre-programmed and autonomous drones without relying on an RF link to the threat.

The interceptor is designed to engage the hostile drone from above using a DefendAir net and then return intact for reuse. A new Net Pod is the only replacement required for another engagement, supporting a low recurring interception cost. The non-explosive mechanism avoids the use of an explosive warhead and the fragmentation associated with explosive interceptors.

TillOnAIR is designed to bring a new set of capabilities to the battlefield. Key elements include:

• Fully autonomous operation: An integrated detection-to-interception cycle designed to require no pilot or operator intervention.
• Modular 360° protection: A configurable architecture providing a 50–100-meter protection bubble around the defended asset.
• Rapid field deployment: Approximately 20-minute setup and an approximately 15 kg system weight support deployment at temporary positions and permanent sites.
• Multiple-threat response: One ground system can coordinate multiple interceptors to address multiple incoming threats.
• Resilience to electronic interference: Ground-based guidance without onboard GPS dependency, combined with physical interception of threats that cannot be stopped by disrupting their communications.
• Reusable interception: The interceptor returns after engagement, with recurring use requiring replacement of the Net Pod.

Within the DefendAir family, TillOnAIR serves as the autonomous perimeter-defense layer. It complements the family’s personal protection systems, vehicle-mounted active protection applications and longer-range airborne integrations, extending ParaZero’s net-based interception capabilities to the defense of positions, facilities and other high-value assets.

TillOnAIR is designed for military assembly areas such as outposts, command posts and field hospitals, where forces require protection that can be established quickly and relocated as operational needs change. Permanent-site applications include government buildings, critical infrastructure, energy facilities, radar stations and air-defense batteries. The system also supports security applications such as VIP protection and public events where non-explosive interception is an important operational consideration.

“TillOnAIR introduces a unique approach to autonomous drone defense: the intelligence and guidance remain on the ground, while a simple, reusable interceptor physically stops the threat,” said Ariel Alon, CEO of ParaZero. “We have brought detection, guidance and interception together in one complete ParaZero system. This expands our role from providing the interception capability to delivering an entire autonomous defense solution, adding a new perimeter-protection layer to the DefendAir family.”

TillOnAIR was presented for the first time at ParaZero’s booth at the AUSA Annual Meeting and Exposition in Washington, D.C. and at the SIBAT – Israeli National Defense Pavilion

During November 2026, ParaZero plans to conduct a series of demonstrations in Israel for government, military, defense, security and other relevant organizations. TillOnAIR is also expected to be presented at the UVID DroneTech show, to be held in Tel Aviv on November 12, 2026. Following the demonstrations in Israel, the Company plans to conduct a series of demonstrations worldwide.

About ParaZero Technologies

ParaZero Technologies Ltd. (Nasdaq: PRZO) is an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry.

Founded in 2014 by aviation professionals and drone industry veterans, ParaZero develops intelligent, mission-ready technologies for defense and advanced aerial applications.

The Company’s DefendAir product family provides a controlled, non-explosive, net-based physical interception capability designed for integration across personal, mobile, autonomous and fixed-site Counter-UAS systems.

For more information, visit ParaZero https://parazero.com/

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act and other securities laws. Forward-looking statements contained in this press release include, but are not limited to, statements regarding ParaZero’s strategic and business plans, technology, relationships, objectives and expectations for its business, growth, the impact of trends on and interest in its business, intellectual property, products and its future results, operations and financial performance and condition and may be identified by the use of words such as “may,” “seek,” “will,” “consider,” “likely,” “assume,” “estimate,” “expect,” “anticipate,” “intend,” “believe,” “do not believe,” “aim,” “predict,” “plan,” “project,” “continue,” “potential,” “guidance,” “objective,” “outlook,” “trends,” “future,” “could,” “would,” “should,” “target,” “on track” or their negatives or variations, and similar terminology and words of similar import, generally involve future or forward-looking statements. For example, the Company is using forward-looking statements when it discusses the anticipated capabilities, performance, cost-efficiency, reusability and potential applications of TillOnAIR, its planned demonstrations in Israel and worldwide, its planned presentation at the UVID DroneTech show, and the expansion of its DefendAir product family.

Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the Company’s Annual Report on Form 20-F filed with the SEC on March 26, 2026. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. ParaZero is not responsible for the content of third-party websites.

Investor Relations Contact:

Michal Efraty
Investor Relations
michal@efraty.com

First Milestone, Monthly Operating Cash Breakeven, Remains an Internal Target for January 2027; CEO Video Update Walks Through the Numbers

Detroit, Michigan, Oct. 26, 2026 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCID:AITX), a developer and operator of AI-driven security and productivity solutions for enterprise clients, today described four operating milestones it intends to use to measure progress toward breakeven. CEO/CTO and founder Steve Reinharz discusses the milestones in a video update available at www.youtu.be/NSPCFNvr4jk.

Each milestone applies a stricter test than the one before it. All four are internal management measures, not measures under generally accepted accounting principles (“GAAP”); see “Important Information Regarding Management Measures” below.

Milestone	Test	Exclusions include these and other items	Internal target (not a projection or guarantee)
1. Monthly operating cash breakeven	Monthly revenue, as recognized, exceeds operating cash paid to operate the Company	Debt service; inventory purchases for device builds	January 2027 (as announced October 21, 2026; previously December 2026
2. Monthly accrual operating breakeven	Monthly revenue exceeds operating expenses as incurred	Depreciation and other non-cash items; deferrals; debt service; inventory purchases	March–April 2027
3. Operating breakeven after cash debt service	Milestone 2, plus debt service paid in cash	Inventory purchases; debt not serviced in cash	Not yet set
4. Full accrual-basis breakeven	Monthly revenue exceeds all expenses as incurred, including debt service and inventory purchases	Depreciation and other non-cash items	Not yet set

“Milestone one is the narrowest of the four measures, reaching it will be a huge step forward,” said Reinharz. “It would show more self-sustainability than this Company has ever had. We are focused on milestones one and two, and as time goes on, I expect to be able to forecast three and four.”

Starting Point

For its fiscal second quarter ended August 31, 2026, the Company reported revenue of $1,985,604, up 8% sequentially and 5% year over year. Revenue from customers other than its largest grew 61% year over year, and that customer’s share of revenue fell to 18% from 46% a year earlier. Recurring device rental revenue represented 89% of total revenue.

Two Levers: Revenue and Cost

The Company’s projection for Milestone 1 assumes revenue growth of approximately 2.7% per month, the pace implied by its second-quarter sequential growth of 8%. “We have two basic levers: increase revenue and decrease cost,” said Reinharz. “Our revenue assumption is based on what the business actually did last quarter.”

On cost, the Company expanded its August target of approximately $200,000 in monthly cash spend reductions to more than $350,000 per month from February 2027, measured against its August 2026 run-rate, as announced October 20, 2026. The program includes a reduction in force of approximately 7 positions in August 2026, as previously announced, and 17 positions in October 2026. It also includes reductions in marketing, promotion, cloud and other operating costs. The Company’s sales force was not affected.

The program also includes salary deferrals, which reduce cash spend faster than they reduce total expenses. Deferred amounts remain obligations of the Company. This is why Milestone 1 measures cash spend and Milestone 2 measures expenses as incurred.

“These were hard decisions, and we don’t take them lightly,” added Reinharz. “We tried to cut costs without significantly affecting our major initiatives or our existing revenue streams.”

In August, the Company expected to reach Milestone 1 in December 2026. As announced October 20, 2026, the expanded program phases in through year-end, and the Company now expects to reach it around January 2027.

Gross Margin

Second-quarter gross margin was 67% excluding a one-time, non-cash inventory write-down of $270,987 related to the discontinued residential camera line, and 54% as reported. Management’s objective is to return gross margin to the 75%–85% range, a level the Company has reached before: gross margin was approximately 83% in its fiscal fourth quarter ended February 28, 2026, as derived from its annual and nine-month results. The hardware price increases effective September 22, 2026 further support that objective.

Debt Service

Certain of the Company’s monthly-repayment loans, including merchant cash advances, are scheduled to be fully repaid beginning in April 2027, which would reduce monthly cash debt service and support progress toward Milestones 3 and 4. This is one data point. The Company’s other debt obligations, including those described in its Quarterly Report on Form 10-Q for the period ended August 31, 2026, could change the timing of those milestones.

Inventory Financing

The Company currently pays cash for the inventory it uses to build devices because it has not obtained inventory financing on acceptable terms. The Company expects inventory needs to grow with ROAMEO^™, RAIA^™ and its existing product lineup. As it reaches Milestones 1 and 2, the Company hopes to become eligible for non-dilutive financing, such as secured, lower-cost inventory financing, rather than the financing it relies on today.

“What we’re hoping happens as we hit milestones one and two is that new, non-dilutive ways to finance inventory become options for us,” concluded Reinharz. “That’s a milestone I can’t wait to get to.”

The Company intends to report progress against these milestones in future updates.

Important Information Regarding Management Measures

The four milestones are management estimates and internal measures, not results achieved, guarantees of future performance or projections of profitability under GAAP. They differ from GAAP net income (loss) and from net cash provided by or used in operating activities, and should not be considered substitutes for those measures. The Company cannot provide a quantitative reconciliation of these forward-looking measures to the most directly comparable GAAP measures without unreasonable effort, because it cannot reliably estimate future working capital changes, non-cash items and other reconciling items.

Revenue recognized in a month does not necessarily equal cash collected in that month. Milestone 1 compares recognized revenue with cash operating expenditures. Salary deferrals and deferred compensation reduce cash expenditures but remain obligations of the Company, and Milestones 1 and 2 exclude them. Milestones 2 through 4 exclude depreciation and other non-cash items. Collection timing, deferred obligations, debt service, inventory purchases and other cash requirements may require financing even if a milestone is reached. Reaching any milestone would not, by itself, establish GAAP profitability, positive net cash provided by operating activities, sufficient liquidity to meet the Company’s obligations or an end to its need for outside financing.

The milestones are not defined under GAAP or any other accounting standard. Management calculates them from internal records, and they have not been audited or reviewed by the Company’s independent registered public accounting firm. Other companies may calculate similarly titled measures differently.

About Artificial Intelligence Technology Solutions, Inc. (AITX)

AITX is a developer and provider of artificial intelligence-based solutions that empower organizations to gain new insight, solve complex challenges and drive operational efficiency. Through its family of companies, including PURSUON, Inc. (formerly RAD-M), Robotic Assistance Devices, Inc. (RAD-I), Robotic Assistance Devices Residential (RAD-R), Robotic Assistance Devices Group (RAD-G), and Robotic Assistance Devices Lanka (Private) Limited (RAD Lanka), AITX develops and delivers a broad range of AI-driven technologies and services designed to transform security, automation, and operational workflows across multiple industries.

Through its primary subsidiary, RAD-I, AITX is redefining the nearly $50 billion U.S. security and guarding services industryⁱ with its AI-driven Solutions-as-a-Service model. RAD solutions are specifically designed to deliver cost savings of between 35% and 80% compared to traditional manned security and monitoring, utilizing a suite of stationary and mobile autonomous systems that complement, and in many cases replace, human personnel in environments better suited for machines. All RAD technologies, AI-based analytics and software platforms are primarily developed in-house.

All of RAD’s solutions are designed to integrate with leading industry platforms and workflows, including an integration with Immix^®, a provider of central station and remote monitoring software. The Company’s operations and internal controls have been validated through successful completion of its SOC 2 Type 2 audit, reinforcing its credibility with enterprise and government clients that require rigorous data protection and compliance standards.

AITX is led by Steve Reinharz, CEO/CTO and founder of the Company and all subsidiaries, who brings decades of experience in the security services industry. The Company’s solutions are deployed across a wide range of industries including enterprises, government, transportation, critical infrastructure, education, and healthcare.

To learn more, visit www.aitx.ai, www.radsecurity.com, www.pursuon.com, www.radgroup.ai, www.saramonitoring.ai, www.radlightmyway.com, and www.stevereinharz.com, or follow Steve Reinharz on X @SteveReinharz. Information contained on, or accessible through, the foregoing websites and social media accounts is not incorporated by reference into, and does not form a part of, this press release or any of the Company’s filings with the Securities and Exchange Commission.

Cautionary Disclosure About Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding the definition, expected timing and achievement of the four milestones; the Company’s previously announced cash breakeven objectives; anticipated monthly revenue growth; anticipated cash spend reductions and the effects of workforce, vendor and operating reductions and salary deferrals; the Company’s gross margin objective; the scheduled repayment of certain loans and its effect on debt service; anticipated inventory requirements for ROAMEO, RAIA and other products; the potential availability of inventory or other non-dilutive financing; the relationship of the milestones to the Company’s previously announced all-in cash breakeven target; negotiations to extend the maturities of the Company’s related-party debt; the proposed increase in the Company’s authorized common stock; and future progress updates.

These statements reflect management’s current expectations and assumptions and are subject to significant risks and uncertainties. Actual results may differ materially. Risks include revenue growth below the assumed rate, which exceeds the Company’s growth over the preceding twelve months; customer attrition, cancellations or deployment delays; delays in billing or collections; cost reductions that are delayed, smaller than anticipated or offset by separation and other costs; deferred compensation and other obligations becoming payable; staffing reductions adversely affecting sales, execution, customer support or retention; gross margin below management’s objective; changes in, or the acceleration, extension or refinancing of, the Company’s debt obligations; debt service, inventory or other cash requirements exceeding expectations; the unavailability of inventory or other financing on acceptable terms or at all; product launch or commercialization delays, including for RAIA and ROAMEO; regulatory restrictions affecting ROAMEO, and substantial dilution from equity or equity-linked financing, from the conversion or exchange of debt and accrued interest, and from any issuance of the additional authorized shares described in the Company’s preliminary information statement filed October 23, 2026.

The Company did not meet its target of positive cash flow by November 2025, has moved its December 2026 breakeven objective to January 2027, and may not reach any milestone within the targeted period, or sustain it once reached.

Other material risks include the Company’s history of losses, negative working capital, stockholders’ deficit, substantial doubt about its ability to continue as a going concern, and the risks described in its most recent Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission. Because the Company’s common stock is a “penny stock,” the safe harbor for forward-looking statements under the Private Securities Litigation Reform Act of 1995 is not available to the Company. Readers should not place undue reliance on these statements, which speak only as of the date of this release. Except as required by law, the Company undertakes no obligation to update them. Although the Company intends to report progress against the milestones, it undertakes no obligation to do so at any particular time or in any particular form, except as required by law. This release does not constitute an offer to sell or the solicitation of an offer to buy securities.

The CEO video update referred to in this release is subject to this cautionary disclosure. The video does not supplement, update or modify this release, and if anything in the video differs from this release, this release controls. Investors should rely only on this release and the Company’s filings with the SEC.

Certain Information Regarding the Company’s Financial Condition

The Company has not been profitable in any fiscal year of its operating history and has reported significant operating losses, negative working capital and a stockholders’ deficit. Its independent auditor’s report includes an explanatory paragraph expressing substantial doubt about the Company’s ability to continue as a going concern. The Company’s cash on hand is insufficient to fund operations for an extended period without additional financing, which may not be available on acceptable terms or at all and may substantially dilute existing stockholders. Investors should review the Company’s Annual Report on Form 10-K for the fiscal year ended February 28, 2026, its Quarterly Report on Form 10-Q for the period ended August 31, 2026, its preliminary information statement on Schedule 14C filed October 23, 2026, and its other SEC filings.

At August 31, 2026, the Company had cash of $220,275, a working capital deficit of $55,894,870, a stockholders’ deficit of $61,690,773 and an accumulated deficit of $184,084,880. Net cash used in operating activities was $4,820,842 for the six months ended August 31, 2026, an average of approximately $803,000 per month, and the Company’s net loss for that period was $12,554,310. In its Quarterly Report on Form 10-Q for that period, management also concluded that substantial doubt exists about the Company’s ability to continue as a going concern.

###

Doug Clemons, Chief Marketing Officer
248-270-8273
doug.c@radsecurity.com

---

ⁱ https://www.ibisworld.com/united-states/market-research-reports/security-services-industry/

Sampo plc, press release, 26 October 2026 at 2:35 pm EET

Sampo will host an Investor Update in London on 17 November 2026

Sampo will host an Investor Update event for analysts and investors on Tuesday 17 November 2026 in London. The event will feature presentations on Sampo’s operational and financial ambitions for the next strategic period from the Group management.

The event can be followed live at www.sampo.com. The programme will start on 17 November at 10:00 am UK time (12:00 pm EET) and will end at around 1:00 pm UK time (3:00 pm EET). The presentations are followed by a Q&A session. Questions can also be sent online during the live webcast.

For further information, please contact:

Diane Michelberger
Head of Investor Relations
tel. +358 10 516 0030

Mirko Hurmerinta
Investor Relations Manager
tel. +358 10 516 0032

Media contacts:
media@sampo.fi

Distribution:
The principal media
www.sampo.com  

ASHBURN, Va., Oct. 26, 2026 (GLOBE NEWSWIRE) — Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced that it will report third quarter 2026 financial results on Monday, November 9, 2026. Management will host a webcast to discuss the Company’s financial results and business outlook at 9:30 a.m. ET.

What:	Telos Corporation Third Quarter 2026 Financial Results Webcast
When:	Monday, November 9, 2026
Time:	9:30 a.m. ET
Webcast:	https://investors.telos.com/news-and-events/events

An on-demand replay of the webcast will be available on the Company’s investor relations website.

About Telos Corporation
Telos Corporation (NASDAQ: TLS) empowers and protects the world’s most security-conscious organizations with efficient, adaptable, and secure solutions that safeguard people, systems, and information. We deliver advanced capabilities across cyber governance, risk, and compliance (GRC) with Xacta^®; identity and biometric solutions; secure networks and communications; and TSA PreCheck^® enrollment services. Serving the U.S. federal government, regulated industries, and global enterprises, Telos helps customers stay ahead of evolving threats, accelerate compliance, and achieve mission success. Driven by purpose and guided by our core values, we build trusted partnerships, deliver superior solutions, and help create a more secure, interconnected world. Learn more at www.telos.com.   

Media:
media@telos.com         

Investors:
InvestorRelations@telos.com

A single device designed to replace months to years of repeat injections, with potential applications well beyond its lead contraception program

VP of Product Development Liz Proos presents Friday, October 30, at 2:30 p.m. ET in Boston

SAN DIEGO, Oct. 26, 2026 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced that Liz Proos, Vice President of Product Development of Daré Bioscience, will present on the Company’s Intelligent Drug Delivery System (DARE-IDDS) at the 16th annual Partnership Opportunities in Drug Delivery (PODD) conference, one of the leading drug delivery industry conferences, taking place October 29–30, 2026 in Boston, MA.

Ms. Proos will present “Expanding Chronic Therapy Adherence with a Single Programmable Device” on Friday, October 30, from 2:30 to 2:50 p.m. ET. The presentation will highlight the potential of DARE-IDDS to address challenges associated with long-term and chronic injection-based therapies by combining programmable drug delivery, wireless communication and dosing flexibility within a single subcutaneously implanted device.

Millions of patients on chronic therapies depend on repeated injections, frequent clinic visits and the discipline to stay on schedule. When patients miss doses, the benefits of even highly effective medicines can be lost. DARE-IDDS is designed to take that burden off the patient.

DARE-IDDS is a single device, implantable under the skin, that is designed to:

• Store and deliver more than 100 discrete doses over periods ranging from months to years
• Program each dose electronically, using independent drug reservoirs and electronic dose control
• Connect wirelessly, with the potential to let patients and healthcare providers monitor and adjust treatment remotely
• Reduce treatment burden, potentially cutting the need for repeated injections, frequent clinic visits and ongoing medication management

By combining extended drug storage with programmable delivery and patient control, DARE-IDDS is being developed to support a range of potential therapeutic applications. The technology is initially being targeted for contraception through Daré Bioscience’s DARE-LARC1 program, which is being developed with the goal of providing a long-acting, reversible contraceptive option designed to give women greater flexibility in managing their reproductive journey. Because DARE-IDDS is a platform, Daré Bioscience believes it may also have applications across other therapeutic areas where adherence, treatment burden and reliable dosing are significant issues, and where future development and commercial partners may see value.

“DARE-IDDS represents an opportunity to rethink how medications are delivered over the long term, particularly in therapeutic areas where adherence and treatment burden can limit the benefits of available therapies,” said Ms. Proos. “By bringing together programmable dosing, wireless connectivity and patient control in a single implantable device platform, we are working to advance a more flexible approach to drug delivery that has the potential to benefit patients, healthcare providers and future development and commercial partners.”

Daré Bioscience has collaborated with Cambridge Consultants, a global product development and technology consultancy, to advance the DARE-IDDS platform, combining drug delivery expertise with capabilities in implantable electronics, connectivity and device engineering. The collaboration reflects Daré Bioscience’s focus on advancing differentiated technology designed to address unmet needs and create new possibilities for patient-centered care.

DARE-IDDS is an investigational device in preclinical development. It has not been approved or cleared for clinical investigation in humans or for any use in humans. The DARE-IDDS features described in this press release are based on the results of technological proof-of-concept studies.

ABOUT DARÉ BIOSCIENCE, INC.

Daré Bioscience (NASDAQ: DARE) is a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions. Every innovation Daré Bioscience advances is based in advanced science and backed by rigorous, peer-reviewed research. From contraception to menopause, sexual health to fertility, vaginal health to infectious disease, Daré Bioscience is working to close critical gaps in care using science that serves her needs. For decades, women have been told to “wait it out” or “live with it,” while innovations that could improve their quality of life languish in the regulatory or funding pipeline. With growing awareness around menopause, sexual health, and vaginal health, the conversation is shifting. However, access to proven solutions is lagging. Daré Bioscience is working to change that. Learn more at darebioscience.com.

FORWARD-LOOKING STATEMENTS

Daré Bioscience cautions you that all statements, other than statements of historical facts, contained in this press release are forward-looking statements. Forward-looking statements, in some cases, can be identified by terms such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “design,” “intend,” “expect,” “could,” “plan,” “potential,” “prepare,” “progress,” “seek,” “should,” “would,” “build” or the negative version of these words and similar expressions.

In this press release, forward-looking statements include, but are not limited to, statements relating to: the potential capabilities of DARE-IDDS as part of a therapeutic product for humans, including storing and delivering more than 100 discrete doses over periods ranging from months to years, electronic dose programming, and wireless connectivity enabling remote treatment monitoring and adjustment; the potential of DARE-IDDS to improve treatment adherence and reduce treatment burden; the potential application of DARE-IDDS in a broad range of therapeutic areas; the therapeutic and market potential of future products utilizing DARE-IDDS; continued development of DARE-LARC1 and its potential to demonstrate safety and effectiveness as a long-acting reversible contraceptive product; and the potential for Daré Bioscience to enter into strategic collaborations for development and commercialization of therapeutic products utilizing DARE-IDDS.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Daré Bioscience’s actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by the forward-looking statements in this press release, including, without limitation, risks and uncertainties related to: advancing DARE-LARC1 and any future product candidate utilizing DARE-IDDS through preclinical stage development and into human clinical trials; the ability of product candidates utilizing DARE-IDDS to demonstrate acceptable safety, tolerability and efficacy, including contraceptive effectiveness, in humans; the potential that product candidates utilizing DARE-IDDS may not demonstrate the dose capacity, duration of drug storage and delivery, or wireless connectivity and remote treatment monitoring and adjustment functionality anticipated based on technological proof-of-concept studies of DARE-IDDS; the risk that positive findings in technological proof-of-concept studies, other nonclinical studies and/or early clinical studies of a product candidate may not be predictive of success in subsequent clinical and/or nonclinical studies of that candidate; delays, increased costs, or failure in completing necessary nonclinical and clinical studies of a product candidate, including due to unanticipated requirements for additional testing; potentially more complex, costly or lengthy development and approval requirements for drug-device combination product candidates; delays or failure to obtain U.S. Food and Drug Administration (FDA) or foreign regulatory approval for a product candidate; achieving anticipated treatment adherence or reduction in treatment burden benefits with any DARE-IDDS-based product, if approved; difficulties establishing and maintaining relationships with development and/or commercial collaborators; Daré Bioscience’s dependence on third parties to conduct nonclinical and clinical studies and manufacture and supply clinical trial material and commercial product, and the performance and resource commitments of such third parties; difficulties in manufacturing drug product candidates and their components at the required quality, stability and scale for clinical trials and commercialization; Daré Bioscience’s ability to obtain additional capital when and as needed to execute its business strategy and continue as a going concern; dependence on grants and other financial awards from governmental entities and a private foundation and the risk that such funding may be reduced, delayed, or terminated, or may be insufficient to advance a product candidate into or through a particular stage of development as anticipated; potential suspension and delisting of Daré Bioscience’s common stock from The Nasdaq Capital Market; failure of any products, if approved, to gain market acceptance or obtain adequate coverage, pricing and reimbursement from third-party payors; the risk that developments by competitors make Daré Bioscience’s products or product candidates less competitive or obsolete; Daré Bioscience’s ability to retain its licensed rights to develop and commercialize a product or product candidate; Daré Bioscience’s ability to satisfy the monetary obligations and other requirements in connection with its exclusive in-license agreements covering the critical patents and related intellectual property related to its products and product candidates; Daré Bioscience’s ability to adequately protect or enforce its, or its licensor’s, intellectual property rights; the lack of patent protection for the active ingredients in certain of Daré Bioscience’s product candidates, which could expose its products to competition from other formulations using the same active ingredients; product liability claims; governmental investigations or actions relating to Daré Bioscience’s products or product candidates or the business activities of Daré Bioscience, its commercial collaborators or other third parties on which Daré Bioscience relies; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; the effects of macroeconomic conditions, geopolitical events, and major changes and disruptions in U.S. government policies and operations on Daré Bioscience’s ability to raise additional capital or on Daré Bioscience’s operations, financial results and condition, and ability to achieve current plans and objectives; and cybersecurity incidents or similar events that compromise Daré Bioscience’s technology systems and/or significantly disrupt Daré Bioscience’s business or those of third parties on which Daré Bioscience relies.

Daré Bioscience’s forward-looking statements are based upon its current expectations and involve assumptions that may never materialize or may prove to be incorrect. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. For a detailed description of Daré Bioscience’s risks and uncertainties, you are encouraged to review its documents filed with the U.S. Securities and Exchange Commission (SEC), including Daré Bioscience’s recent filings on Form 8-K, Form 10-K and Form 10-Q. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Daré Bioscience undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

Contact:
Daré Bioscience Investor Relations
innovations@darebioscience.com

Source: Daré Bioscience, Inc.

New platform connects domain experts with mission-critical AI work as companies compete for the human expertise needed to move AI from innovation to execution

NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) — iMerit, an EXL company, today announced the launch of its iMerit Scholars platform, designed to seamlessly manage hundreds of thousands of global domain experts (Scholars) who work on fine-tuning, evaluation and validation of generative AI models. This represents the first major launch since EXL (Nasdaq: EXLS) acquired iMerit in July to accelerate the progression of frontier AI into regulated enterprises.

The launch comes as the AI talent war heats up across generative and physical AI. The iMerit Scholars program already brings together a curated global community of 30,000 domain experts and linguists to support advanced model training, evaluation, validation and safety across specialized fields. The new iMerit Scholars platform provides a unified system to recruit, onboard, curate, assign, manage, engage, pay, and retain these experts at scale. It is powered by iMerit’s proprietary Ango Hub, which allows customers and experts to collaborate on complex multimodal data to generate highly curated and validated training artifacts for high-stakes models. 

“iMerit has always differentiated itself by a curated, people-first approach. We’re seeing that become even more important as we scale up to help the frontier labs,” said Radha Basu, executive vice president, head of iMerit at EXL. “The next phase of the GenAI race is about creating a painless and supportive infrastructure so that these highly capable specialists can enjoy their work and give their best. Scaling high quality and high engagement is mainly a human capital opportunity, backed by enabling technology. The iMerit Scholars platform is designed to create a seamless experience for top-notch talent to continue building and improving the next generation of AI.”

“Now, as a part of EXL, we are expanding from the creation of models in frontier labs to the implementation of model workflows in highly regulated enterprises in banking, healthcare and insurance. Once again, we find that trust, safety, and last-mile customization will dictate the success of AI projects in these sectors. We need people who are knowledgeable enough not just to teach models, but to prove them wrong and correct them. That parallel human authority is what will help move AI from innovation to trusted execution,” added Basu.

Leveraging Trolley’s global payouts platform, iMerit Scholars incorporates compliance and global secure payments to create a mutually beneficial environment for customers and experts. 

The iMerit Scholars program was built to meet the need for structured reasoning, domain nuance, and ongoing evaluation across high-stakes use cases in healthcare, physical AI, finance, and foundation models. The iMerit Scholars community brings together over 30,000 invited and vetted professionals from 118 countries representing 106 languages across fields such as medicine, mathematics, agriculture, linguistics, and autonomous systems. iMerit works with them to test, challenge, and “torment” models, helping improve performance in real-world conditions through techniques like RLHF, red-teaming, Q&A prompting, chain-of-thought tracing, and evaluation.

The iMerit Scholars platform matches experts with projects aligned to their specialization, enabling more consistent engagement and higher-quality outcomes. iMerit Scholars platform also introduces new capabilities to support this evolving workforce model, including:

• Expert matching based on domain specialization and cognitive skill sets
• Secure, compliant workflows for sensitive data environments
• Global payments and workforce infrastructure through Trolley
• Integrated tooling for training, evaluation, and model feedback loops

For experts, iMerit Scholars platform represents a move from fragmented experiences to a meaningful, ongoing relationship.

“Working with AI in this way feels like contributing to something foundational,” said Pavel Kopach, M.D. Department of Pathology, Beth Israel Deaconess Medical Center, and iMerit Scholar in Healthcare AI. “You’re not just labeling data, you’re helping shape how these systems reason and behave in your field. That’s both challenging and incredibly rewarding.”

To learn more about iMerit, an EXL company, visit iMerit.ai.

About EXL

EXL (NASDAQ: EXLS) is a global data and AI company that offers services and solutions to reinvent client business models, drive better outcomes and unlock growth with speed. EXL harnesses the power of data, AI, and deep industry knowledge to transform businesses, including the world’s leading corporations in industries including insurance, healthcare, banking and capital markets, retail, communications and media, and energy and infrastructure, among others. EXL was founded in 1999 with the core values of innovation, collaboration, excellence, integrity and respect. We are headquartered in New York and have approximately 68,000 employees spanning six continents. For more information, visit www.exlservice.com.

Media Contact: imerit@inkhouse.com 

GEORGE TOWN, Grand Cayman, Oct. 26, 2026 (GLOBE NEWSWIRE) — Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water treatment plants, will hold a conference call on Tuesday, November 10, 2026 at 11:00 a.m. Eastern time to discuss its results for the third quarter ended September 30, 2026.

The financial results will be issued in a press release prior to the call. Consolidated Water management will host the call, followed by a question-and-answer period.

Date: Tuesday, November 10, 2026
Time: 11:00 a.m. Eastern time (8:00 a.m. Pacific time)
Toll-free dial-in number: 1-844-875-6913
International dial-in number: 1-412-317-6709
Participant web phone: click here

Please call the conference telephone number five minutes prior to the start time. An operator will register your name and organization. If you require any assistance connecting with the call, please contact Encore at 1-949-432-7450.

A replay of the call will be available after 1:00 p.m. Eastern time on the same day through November 17, 2026, as well as available for replay via the Investors section of the Consolidated Water website at www.cwco.com.

Toll-free replay number: 1-855-669-9658
International replay number: 1-412-317-0088
Replay ID: 5866966

About Consolidated Water Co. Ltd.
Consolidated Water Co. Ltd. develops and operates advanced water treatment plants and water distribution systems. The company designs, constructs and operates seawater desalination facilities in the Cayman Islands, The Bahamas and the British Virgin Islands, and designs, constructs and operates water treatment and reuse facilities in the United States.

The company also manufactures and services a wide range of products and provides design, engineering, management, operating and other services applicable to commercial and municipal water production, supply and treatment, and industrial water and wastewater treatment.

For more information, visit cwco.com.

Company Contact:
David W. Sasnett
Executive Vice President and CFO
Tel (954) 509-8200
Email Contact

Investor & Media Contact:
Ron Both or Grant Stude
Encore Investor Relations
Tel (949) 432-7450
Email Contact